<bill session="108" type="s" number="518" updated="2023-01-15T22:48:21Z">
  <state datetime="2004-09-22">REPORTED</state>
  <status>
    <unknown datetime="2004-09-22"/>
  </status>
  <introduced datetime="2003-03-05"/>
  <titles>
    <title type="display">Pancreatic Islet Cell Transplantation Act of 2004</title>
    <title type="official" as="introduced">A bill to increase the supply of pancreatic islet cells for research, to provide better coordination of Federal efforts and information on islet cell transplantation, and to collect the data necessary to move islet cell transplantation from an experimental procedure to a standard therapy.</title>
    <title type="short" as="reported to senate">Pancreatic Islet Cell Transplantation Act of 2004</title>
    <title type="short" as="introduced">Pancreatic Islet Cell Transplantation Act of 2003</title>
  </titles>
  <sponsor bioguide_id="C001035"/>
  <cosponsors>
    <cosponsor bioguide_id="A000360" joined="2003-06-05"/>
    <cosponsor bioguide_id="A000121" joined="2003-03-17"/>
    <cosponsor bioguide_id="B000444" joined="2003-04-03"/>
    <cosponsor bioguide_id="B000468" joined="2003-03-27"/>
    <cosponsor bioguide_id="B000611" joined="2003-05-12"/>
    <cosponsor bioguide_id="B000711" joined="2003-06-24"/>
    <cosponsor bioguide_id="B000780" joined="2003-03-05"/>
    <cosponsor bioguide_id="B001066" joined="2003-03-06"/>
    <cosponsor bioguide_id="B001126" joined="2003-06-25"/>
    <cosponsor bioguide_id="C001040" joined="2003-04-03"/>
    <cosponsor bioguide_id="C000286" joined="2003-03-20"/>
    <cosponsor bioguide_id="C001041" joined="2003-06-18"/>
    <cosponsor bioguide_id="C000567" joined="2003-05-12"/>
    <cosponsor bioguide_id="C001057" joined="2003-06-24"/>
    <cosponsor bioguide_id="C001042" joined="2003-06-11"/>
    <cosponsor bioguide_id="C000858" joined="2003-05-01"/>
    <cosponsor bioguide_id="D000064" joined="2003-03-18"/>
    <cosponsor bioguide_id="D000596" joined="2003-03-17"/>
    <cosponsor bioguide_id="D000294" joined="2003-07-22"/>
    <cosponsor bioguide_id="D000388" joined="2003-06-11"/>
    <cosponsor bioguide_id="D000407" joined="2003-05-12"/>
    <cosponsor bioguide_id="D000432" joined="2003-03-25"/>
    <cosponsor bioguide_id="D000563" joined="2003-05-22"/>
    <cosponsor bioguide_id="E000194" joined="2003-06-04"/>
    <cosponsor bioguide_id="F000061" joined="2003-06-24"/>
    <cosponsor bioguide_id="F000442" joined="2003-05-05"/>
    <cosponsor bioguide_id="G000352" joined="2003-08-01"/>
    <cosponsor bioguide_id="G000359" joined="2003-06-11"/>
    <cosponsor bioguide_id="H001028" joined="2003-05-05"/>
    <cosponsor bioguide_id="H000206" joined="2003-04-03"/>
    <cosponsor bioguide_id="I000024" joined="2003-03-17"/>
    <cosponsor bioguide_id="K000148" joined="2003-06-10"/>
    <cosponsor bioguide_id="L000550" joined="2003-07-08"/>
    <cosponsor bioguide_id="L000123" joined="2003-07-08"/>
    <cosponsor bioguide_id="L000304" joined="2003-06-23"/>
    <cosponsor bioguide_id="L000035" joined="2003-03-18"/>
    <cosponsor bioguide_id="L000447" joined="2003-03-10"/>
    <cosponsor bioguide_id="M000303" joined="2003-04-02"/>
    <cosponsor bioguide_id="M000702" joined="2003-06-23"/>
    <cosponsor bioguide_id="M001141" joined="2003-03-05"/>
    <cosponsor bioguide_id="M001153" joined="2003-07-24"/>
    <cosponsor bioguide_id="M001111" joined="2003-03-05"/>
    <cosponsor bioguide_id="N000180" joined="2003-06-19"/>
    <cosponsor bioguide_id="N000032" joined="2003-09-02"/>
    <cosponsor bioguide_id="R000122" joined="2003-04-01"/>
    <cosponsor bioguide_id="S000064" joined="2003-09-17"/>
    <cosponsor bioguide_id="S000148" joined="2003-06-19"/>
    <cosponsor bioguide_id="S001141" joined="2003-06-04"/>
    <cosponsor bioguide_id="S001142" joined="2003-03-24"/>
    <cosponsor bioguide_id="S000770" joined="2003-07-22"/>
    <cosponsor bioguide_id="T000024" joined="2003-07-22"/>
    <cosponsor bioguide_id="W000154" joined="2003-06-09"/>
  </cosponsors>
  <actions>
    <action datetime="2003-03-05">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-03-05">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S3166"/>
    </action>
    <action datetime="2003-03-05" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2004-09-22" state="REPORTED">
      <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2004-10-07">
      <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Gregg with an amendment in the nature of a substitute. With written report No. 108-387.</text>
    </action>
    <calendar datetime="2004-10-07" calendar="Senate Legislative" under="General Orders" number="773">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 773.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="108" type="h" number="3858" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Accreditation (Medical care)"/>
    <term name="Administrative procedure"/>
    <term name="Blood diseases"/>
    <term name="Cardiovascular diseases"/>
    <term name="Caregivers"/>
    <term name="Child health"/>
    <term name="Clinical trials"/>
    <term name="Communication in medicine"/>
    <term name="Communication in science"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Cost effectiveness"/>
    <term name="Department of Health and Human Services"/>
    <term name="Diabetes"/>
    <term name="Donation of organs, tissues, etc."/>
    <term name="Economics and Public Finance"/>
    <term name="Executive reorganization"/>
    <term name="Eye diseases"/>
    <term name="Families"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to health facilities"/>
    <term name="Federal aid to research"/>
    <term name="Finance and Financial Sector"/>
    <term name="Government Operations and Politics"/>
    <term name="Governmental investigations"/>
    <term name="Insulin"/>
    <term name="Labor and Employment"/>
    <term name="Labor productivity"/>
    <term name="Law"/>
    <term name="Legislation"/>
    <term name="Medical economics"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="Nervous system diseases"/>
    <term name="Quality of life"/>
    <term name="Research grants"/>
    <term name="Science, Technology, Communications"/>
    <term name="Sick leave"/>
    <term name="Social Welfare"/>
    <term name="Transplantation of organs, tissues, etc."/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in Senate">Pancreatic Islet Cell Transplantation Act of 2003 - Amends the Public Health Service Act to include pancreases procured by an organ procurement organization and used for islet cell transplantation or research to be counted toward organ procurement organization certification.Establishes the Interagency Committee on Islet Cell Transplantation within the Department of Health and Human Services (HHS). Requires the Committee to study related issues, including Federal research funding, the effect of specified policies on transplantation, and data collection.Instructs the Secretary of HHS to request the Institute of Medicine to provide a study of the impact of islet cell transplantation on juvenile diabetes patients, including their health and the treatment's cost-effectiveness.Directs the Secretary, acting through the Administrator of the Centers for Medicare &amp; Medicaid Services, to establish a demonstration project to assess the efficacy of pancreatic cell islet transplantation for individuals who: (1) have Type I diabetes; and (2) have end-stage renal disease; and (3) are Medicare beneficiaries. Limits to six the number of eligible facilities that can participate in the project. Directs the Secretary to conduct an evaluation of the outcomes under the project and report to Congress. Allows the Secretary to waive such requirements of titles XI (General Provisions) and XVIII (Medicare) of the Social Security Act as are necessary to carry out the project.Authorizes appropriations.</summary>
  <committee-reports>
    <report>S. Rept. 108-387</report>
  </committee-reports>
</bill>
